Re: Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.
Ménard
Sylvie
S
Casalini
Patrizia
P
Tagliabue
Elda
E
Pupa
Serenella M
SM
Balsari
Andrea
A
D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000737:chemistry / Q000517:prevention & control*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007044:Hysterectomy; D007558:Italy / Q000453:epidemiology; D008403:Mass Screening; D009376:Neoplasms, Hormone-Dependent / Q000737:chemistry / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use*; D015854:Up-Regulation
D016588:Anticarcinogenic Agents; D018931:Antineoplastic Agents, Hormonal; D018719:Erb-b2 Receptor Tyrosine Kinases; D013629:Tamoxifen